Technology
Health
Medical

NuVasive

$56.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.90 (1.61%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell NuVasive and other stocks, options, ETFs, and crypto commission-free!

About

NuVasive, Inc. engages in the development of minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. It offers cervical and spine fusion surgery, cervical plating, and posterior fixation products. Read More The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA.

Employees
2,600
Headquarters
San Diego, California
Founded
1997
Market Cap
2.89B
Price-Earnings Ratio
257.09
Dividend Yield
0.00
Average Volume
705.68K
High Today
$57.06
Low Today
$55.88
Open Price
$56.01
Volume
109.73K
52 Week High
$72.41
52 Week Low
$43.51

Collections

Technology
Health
Medical
US
North America

News

Yahoo FinanceMar 22

NuVasive (NUVA) Down 1% Since Last Earnings Report: Can It Rebound?

NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. A month has gone by since the last earnings report for NuVasive (NUVA). Shares have lost about 1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is NuVasive due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earni...

7
PR NewswireMar 20

GTCR Announces Partnership with Healthcare Leader Gregory T. Lucier to Form Corza Health

CHICAGO, March 20, 2019 /PRNewswire/ -- GTCR, a leading private equity firm, today announced that it has entered into a partnership with Gregory T. Lucier to form Corza Health, Inc.

4
MarketBeatMar 17

Stock Price, News, & Analysis for NuVasive

NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company's principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring ...

0

Earnings

$0.39
$0.49
$0.59
$0.69
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 30, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.